Skip to main content
About us
About us
Governance
IDDO Team
Our partners
Contact us
Jobs
Data
Explore data
Accessing data
Data Access Guidelines
Contributing data
Why share your data
Frequently Asked Questions
IDDO legal and regulatory documentation
Science
Science
WWARN malaria
COVID-19
Ebola
Visceral leishmaniasis
Medicine Quality
Antimicrobial Resistance
Schistosomiasis & STHs
Chagas Disease
Febrile illness
Scrub typhus
Trachoma
Other diseases
Equity
Our approach
IDDO Blogs
News
Publications
About us
About us
Governance
IDDO Team
Our partners
Contact us
Jobs
Data
Explore data
Accessing data
Data Access Guidelines
Contributing data
Why share your data
Frequently Asked Questions
IDDO legal and regulatory documentation
Science
Science
WWARN malaria
COVID-19
Ebola
Visceral leishmaniasis
Medicine Quality
Antimicrobial Resistance
Schistosomiasis & STHs
Chagas Disease
Febrile illness
Scrub typhus
Trachoma
Other diseases
Equity
Our approach
IDDO Blogs
News
Publications
LOGIN
Please note that the content has been automatically translated from English original. There may on occasion be slight inaccuracies in this automatic translation
All Tools and Resources
Keyword search
Research theme
- Any -
Antimicrobial resistance
Chagas
COVID19
Febrile Illness
New Diseases
Schistosomiasis & STHs
Ebola
Malaria
Visceral leishmaniasis
Medicine quality
Search
On-site monitoring
Procedure
Organising trial initiation meetings
Procedure
Oxford Statement - Spanish version
Document
P. vivax Drug Efficacy: Protocol Template
Document
Packaging and labeling investigational products/study drugs
Procedure
Patient Book Extract
Document
PCE CSV file template
Document
PCE Example Automated Report
Document
PCE Methodology
Document
PCE Terms of Use
Document
Pagination
First page
« First
Previous page
‹‹ Prev
…
Page
18
Page
19
Page
20
Page
21
Current page
22
Page
23
Page
24
Page
25
Page
26
…
Next page
Next ››
Last page
Last »